University of Wisconsin Transplant Infectious Disease Fellowship

• Leading solid organ transplant center, including heart, lung, liver, kidney, pancreas and multiorgan transplants; only the third center to reach 20,000 individuals transplanted
• High-volume hematologic malignancy program, including CAR-T and stem cell transplantation
• Unparalleled research opportunities through resources at our university, clinic centers, and international research networks

• Co-located training at a top-rated VA Hospital, which is a nationally recognized leader in the care of veterans receiving solid organ transplants 
• Training that’s highly individualized to your interests and needs

We are currently accepting applications on a rolling basis for the July 2025-June 2026 academic year, until the position is filled or February 1, 2025. 

An eligible candidate will have completed at least two years of an ACGME-accredited general ID fellowship, and be board eligible or certified in infectious diseases. 

We are only able to sponsor J1 visas at this time.

Applicants should submit:

• Current curriculum vitae
• One-page personal statement
• Letter from an ACGME-accredited infectious disease fellowship program director indicating satisfactory performance in a general infectious disease fellowship
• Two additional letters of recommendation

Email your materials to GME program manager Erica Mishek.

If a decision is made to interview, we'll arrange a mutually acceptable date and time for a virtual interview.

• Jeannina Smith, MD
• Elizabeth Misch, MD
• Kristine Matson, MD, MPH
• Michelle Gionet, PA
• Amy Gentry, NP

All Division of Infectious Disease faculty and advanced practice providers

Didactic and Clinical Experiences

Our clinical fellowship in transplant infectious disease offers wide-ranging opportunities in direct patient care, antimicrobial stewardship, infection control, guideline development, research and quality improvement. We highly individualize your schedule; here is a general outline.

• Immunocompromised Host Consult Service: 24 weeks
• Antimicrobial Stewardship and CMV Monitoring Service: 2 weeks
• Infection Control Service: 2 weeks
• Infectious Disease Clinic: One half-day per week
• Participation in antimicrobial stewardship and infection control committees, as well as regular attendance at organ selection committee meetings
• Remaining time to be used at fellow discretion for electives, quality improvement projects, scholarship and other professional development

Scholarship

Faculty mentorship will allow you to succeed in your chosen area of scholarship. The division boasts relevant expertise in drug development, mycology, Clostridioides difficile, CMV, COVID-19, population health and medical education.

Recent highlighted publications

• Scolarici MJ, Berman LR, Callander N, Smith J, Saddler C. Infective endocarditis is rare in patients with hematologic malignancy and neutropenia. Transpl Infect Dis. 2024 Jun;26(3):e14302. doi: 10.1111/tid.14302. Epub 2024 May 18. PMID: 38761053.
• Jorgenson MR, Parajuli S, Kleiboeker HL, Felix DC, Astor BC, Saddler CM, Smith JA, Mandelbrot DA. Incidence and outcomes of fever of unknown origin after kidney transplant in the modern era. Clin Transplant. 2024 Jan;38(1):e15217. doi: 10.1111/ctr.15217. Epub 2023 Dec 11. PMID: 38078682.
• Jorgenson MR, Descourouez JL, Kleiboeker H, Goldrosen K, Schulz L, Rice JP, Odorico JS, Mandelbrot DA, Smith JA, Saddler CM. Cytomegalovirus antiviral stewardship in solid organ transplant recipients: A new gold standard. Transpl Infect Dis. 2022 Oct;24(5):e13864. doi: 10.1111/tid.13864. PMID: 35603982.
• Scolarici M, Jorgenson M, Saddler C, Smith J. Fungal Infections in Liver Transplant Recipients. J Fungi (Basel). 2021 Jun 29;7(7):524. doi: 10.3390/jof7070524. PMID: 34210106; PMCID: PMC8304186.
• Jorgenson MR, Descourouez JL, Schulz LT, Goldrosen KA, Rice JP, Redfield RR, Saddler CM, Smith JA, Mandelbrot DA. The development and implementation of stewardship initiatives to optimize the prevention and treatment of cytomegalovirus infection in solid-organ transplant recipients. Infect Control Hosp Epidemiol. 2020 Sep;41(9):1068-1074. doi: 10.1017/ice.2020.203. Epub 2020 May 27. PMID: 32456718.
• Cheng YW, Phelps E, Ganapini V, Khan N, Ouyang F, Xu H, Khanna S, Tariq R, Friedman-Moraco RJ, Woodworth MH, Dhere T, Kraft CS, Kao D, Smith J, Le L, El-Nachef N, Kaur N, Kowsika S, Ehrlich A, Smith M, Safdar N, Misch EA, Allegretti JR, Flynn A, Kassam Z, Sharfuddin A, Vuppalanchi R, Fischer M. Fecal microbiota transplantation for the treatment of recurrent and severe Clostridium difficile infection in solid organ transplant recipients: A multicenter experience. Am J Transplant. 2019 Feb;19(2):501-511. doi: 10.1111/ajt.15058. Epub 2018 Aug 31. PMID: 30085388; PMCID: PMC6349556.

Teaching

Alongside our general infectious disease fellows, you’ll have the opportunity to supervise medical students and internal medicine residents. You will present grand rounds to the division and have abundant opportunity to share interesting cases at weekly TID case conference.

For those interested in formal educator skills development, we encourage participation in our Fellow as Medical Educator (FAME) training track.

By the end of the training year, fellows should be able to:

• Conduct a thorough pre-transplant infectious disease evaluation and counsel patients on the risks of infection following transplantation
• Outline evidence-based approach to infection prevention among immunocompromised patients, including appropriate use of antibacterial, antiviral and antifungal agents and vaccination
• Manage nosocomial and surgical site infections following solid organ transplantation in close collaboration with our transplant surgery colleagues
• Diagnose and manage opportunistic infections among solid organ and stem cell transplant recipients
• Implement high yield interventions to promote antimicrobial stewardship among solid organ and stem cell transplant recipient populations